title: Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse.
abstract: The leukotriene modifiers are a novel generation of therapeutic agents in the treatment of allergic asthma. However, the mechanisms by which the cysteinyl (cys) leukotrienes (LTs) participate in allergen-induced airway eosinophilia and airway hyperresponsiveness (AHR) are still unclear. In the present study, we have investigated the role of cys-LTs in ovalbumin (OVA)-induced airway responses in a murine model of asthma. Montelukast (3 or 10 mg/kg), a selective cys-LT1 receptor antagonist, reduced airway eosinophilia and AHR after OVA challenge. The levels of interleukin (IL)-5 and eotaxin in the bronchoalveolar lavage fluid (BALF) from montelukast-treated (3 mg/kg) mice were unaffected, although a decrease in IL-5 was observed with a dose of 10 mg/kg. LTD4 (50 ng) instilled intranasally to immunized mice augmented macrophages in the BALF, but in conjunction with OVA challenge it caused BALF eosinophilia and neutrophilia when given before challenge and BALF neutrophilia but not eosinophilia when given 2 h after challenge. However, there were no increases of IL-5 or eotaxin in BALF following LTD4 treatment. Repeated instillations of LTD4 to immunized mice, mimicking allergen challenge, did not induce AHR but in conjunction with OVA challenge LTD4 enhanced AHR. These results indicate that allergen-induced eosinophilia and AHR are in part mediated by the cys-LT1 receptor, and that, although LTD4 alone has no effect on airway eosinophilia, in conjunction with antigenic stimulation it potentiates the degree of airway inflammation and AHR.
authors.affiliation: Meakins-Christie Laboratories and Respiratory Division, Department of Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Seok-Yong
authors.initials: SY
authors.lastname: Eum
authors.forename: Karim
authors.initials: K
authors.lastname: Maghni
authors.forename: Qutayba
authors.initials: Q
authors.lastname: Hamid
authors.forename: Holly
authors.initials: H
authors.lastname: Campbell
authors.forename: David H
authors.initials: DH
authors.lastname: Eidelman
authors.forename: James G
authors.initials: JG
authors.lastname: Martin
mesh_terms: D000085:Acetates / Q000494:pharmacology; D000485:Allergens / Q000276:immunology*; D000818:Animals; D001980:Bronchi / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000503:physiopathology*; D001992:Bronchoalveolar Lavage Fluid; D054413:Chemokine CCL11; D019742:Chemokines, CC / Q000378:metabolism; D003521:Cyclopropanes; D004802:Eosinophilia / Q000503:physiopathology*; D015848:Interleukin-5 / Q000378:metabolism; D015289:Leukotrienes / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011804:Quinolines / Q000494:pharmacology; D013440:Sulfides
chemical_list: D000085:Acetates; D000485:Allergens; C515457:Ccl11 protein, mouse; D054413:Chemokine CCL11; D019742:Chemokines, CC; D003521:Cyclopropanes; D015848:Interleukin-5; D015289:Leukotrienes; D011804:Quinolines; D013440:Sulfides; C093875:montelukast